Literature DB >> 23396998

The pathogenetic enigma of polycystic ovary syndrome.

S Speca1, C Napolitano, G Tagliaferri.   

Abstract

Polycystic ovary syndrome (PCOS) is a complex disease with heterogeneous clinical and anatomical features that were first described in 1721 by Antonio Vallisneri. There is still a lack of consensus regarding the criteria to be used for diagnosis of PCOS. Transvaginal ultrasonography with Doppler studies of the ovarian and pelvic vasculature plays an important role in its diagnosis, but findings must be interpreted in light of the patient's symptoms and laboratory findings.

Entities:  

Keywords:  Hyperandrogenism; Metabolic syndrome; PCOS; Ultrasonography

Year:  2007        PMID： 23396998      PMCID： PMC3553224          DOI： 10.1016/j.jus.2007.09.006

Source DB:  PubMed          Journal:  J Ultrasound        ISSN： 1876-7931


  50 in total

1.  Insulin infusion amplifies 17 alpha-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: apparent relative impairment of 17,20-lyase activity.

Authors:  P Moghetti; R Castello; C Negri; F Tosi; G G Spiazzi; E Brun; R Balducci; V Toscano; M Muggeo
Journal:  J Clin Endocrinol Metab       Date:  1996-03       Impact factor: 5.958

2.  Color Doppler analysis in lean and obese women with polycystic ovary syndrome.

Authors:  C Battaglia; P G Artini; A D Genazzani; M R Sgherzi; M Salvatori; S Giulini; A Volpe
Journal:  Ultrasound Obstet Gynecol       Date:  1996-05       Impact factor: 7.299

3.  Transvaginal three-dimensional ultrasound: reproducibility of ovarian and endometrial volume measurements.

Authors:  A Kyei-Mensah; N Maconochie; J Zaidi; R Pittrof; S Campbell; S L Tan
Journal:  Fertil Steril       Date:  1996-11       Impact factor: 7.329

Review 4.  Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy.

Authors:  R Homburg
Journal:  Hum Reprod       Date:  1996-01       Impact factor: 6.918

5.  Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification.

Authors:  Y Robert; F Dubrulle; L Gaillandre; Y Ardaens; P Thomas-Desrousseaux; L Lemaitre; D Dewailly
Journal:  Fertil Steril       Date:  1995-08       Impact factor: 7.329

6.  Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.

Authors:  D Apter; T Bützow; G A Laughlin; S S Yen
Journal:  J Clin Endocrinol Metab       Date:  1995-10       Impact factor: 5.958

7.  Relationship between ultrasonography and histopathological changes in polycystic ovarian syndrome.

Authors:  K Takahashi; T Ozaki; M Okada; A Uchida; M Kitao
Journal:  Hum Reprod       Date:  1994-12       Impact factor: 6.918

8.  Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.

Authors:  E Diamanti-Kandarakis; A Mitrakou; M M Hennes; D Platanissiotis; N Kaklas; J Spina; E Georgiadou; R G Hoffmann; A H Kissebah; S Raptis
Journal:  Metabolism       Date:  1995-04       Impact factor: 8.694

9.  Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

Authors:  R J Norman; W M Hague; S C Masters; X J Wang
Journal:  Hum Reprod       Date:  1995-09       Impact factor: 6.918

10.  Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients.

Authors:  A H Balen; G S Conway; G Kaltsas; K Techatrasak; P J Manning; C West; H S Jacobs
Journal:  Hum Reprod       Date:  1995-08       Impact factor: 6.918
View more
  2 in total

1.  The Higher Response of Vascular Endothelial Growth Factor and Angiotensin-II to Human Chorionic Gonadotropin in Women with Polycystic Ovary Syndrome.

Authors:  Junwei Qu; Yena Che; Pei Xu; Yanjie Xia; Xiaoke Wu; Yong Wang
Journal:  Int J Fertil Steril       Date:  2015-02-07

2.  IGF-1R and Leptin Expression Profile and the Effects of Metformin Treatment on Metabolic and Endocrine Parameters in PCOS Mice.

Authors:  Luis Eduardo Prado Correia; Bruna Cristine de Almeida; Manuel de Jesus Simões; Mauro Abi Haidar; Daniela Berguio Vidotti; Ivaldo Silva
Journal:  Biomed Res Int       Date:  2017-12-21       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.